Status:
COMPLETED
Pharmacological Management of Delirium
Lead Sponsor:
Indiana University
Collaborating Sponsors:
National Institute on Aging (NIA)
Conditions:
Delirium
Cognitive Impairment
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to develop and test the feasibility of using a specific pharmacological protocol to reduce delirium burden among older adults in the Intensive Care Unit (ICU). The study w...
Detailed Description
In 2005, approximately 2.7 million Americans aged 65 and older spent at least one day in the intensive care unit (ICU), costing Medicare an estimated $27.5 billion. It is estimated that while hospital...
Eligibility Criteria
Inclusion
- 18 years of age or older
- Hospitalized on an ICU ward
- Delirium based on the RASS and the CAM-ICU assessments at any day during ICU stay
- English speaking
Exclusion
- Admitted directly to a regular non-ICU ward
- Previously enrolled in the study
- Not eligible for delirium assessment as determined by RASS scores
- Prior history of severe mental illness
- Alcohol-related delirium
- Pregnant or nursing
- Have had an aphasic stroke
Key Trial Info
Start Date :
February 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2015
Estimated Enrollment :
551 Patients enrolled
Trial Details
Trial ID
NCT00842608
Start Date
February 1 2009
End Date
July 1 2015
Last Update
August 17 2018
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Eskenazi Hospital
Indianapolis, Indiana, United States, 46202
2
Methodist Hospital
Indianapolis, Indiana, United States, 46202
3
University Hospital
Indianapolis, Indiana, United States, 46202